Company intelligence / Profile preview

Genoptix

Carlsbad, California, United States

Ownership: Private
Development stage: Other

Overview

Genoptix specialized in providing comprehensive diagnostic services for hematologic cancers (leukemia, lymphoma, bone marrow disorders) and later for solid tumor molecular profiling, employing integrated platforms including morphology, flow cytometry, cytogenetics, FISH, and next-generation sequencing panels. It became one of the largest hematopathology centers in the U.S.

Therapeutic areas: OncologyHematology
Modalities: Diagnostic service
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Genoptix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genoptix.

Explore the full profile